KaloBios Pharmaceuticals Inc KBIO filed for Chapter 11 bankruptcy protection Tuesday in the U.S. bankruptcy court for the District of Delaware, reports Reuters. The company listed assets and liabilities of $1 million to $10 million,
Also on Tuesday KaloBios announced it was appealing Nasdaq's decision to delist its shares. KaloBios shares have been halted since December 17, the same day its controversial CEO Martin Shkreli was arrested on securities fraud and wire fraud charges.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in